Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2023 Mar 31;11(5):345–361. doi: 10.1016/S2213-8587(23)00038-4

Figure 3. Management of patients with SDHD-related HNPGLs with special emphasis on tumor multifocality.

Figure 3.

Jugular PGLs are also named jugulotympanic PGLs; SRS, stereotactic radiosurgery (preferred radiotherapeutic option); RT, hypofractionated radiotherapy; CN, cranial neuropathy; PD, progressive disease; MET, metastatic; TRT, targeted radionuclide therapy; Adx, adrenalectomy; HNPGLs, head and neck paragangliomas; PGL, paraganglioma; VCT, vocal cord palsy

*For patients without preoperative neuropathy

#Some authors prefer to start on the side of the larger tumor